ArticleScientific reports2026
YTHDC1 modulates the malignant phenotype of retinoblastoma via SQSTM1-mediated autophagy.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
Abstract
Retinoblastoma (RB) is the most common pediatric intraocular malignancy, yet the role of N6-methyladenosine (m6A) regulators in RB progression remains unclear. This study investigated the function and mechanism of the m6A reader YTHDC1 in RB invasion. The RNA-sequencing dataset GSE97508 from Gene Expression Omnibus was analyzed to identify differentially expressed m6A regulators between invasive and non-invasive RB. Their expression was next validated by RT-qPCR, Western blot, and immunohistochemistry. Functional assays including CCK-8, EdU, and Transwell assays were performed to evaluate the effects of YTHDC1 knockdown or overexpression on RB cells in vitro and in vivo. SQSTM1 was predicted to be a downstream target by bioinformatics and experimental validation. RNA stability and RIP-qPCR assays were performed to examine the regulation of SQSTM1 mRNA by YTHDC1. Autophagic flux was evaluated by LC3B Western blotting and mCherry-GFP-LC3B fluorescence imaging. YTHDC1 was significantly downregulated in invasive RB. YTHDC1 knockdown enhanced, whereas its overexpression suppressed, RB cell proliferation and invasion. YTHDC1 promoted SQSTM1 expression by stabilizing its mRNA. Knockdown of SQSTM1 in RB cells promoted cell proliferation, migration, and invasion, and partially counteracted the inhibition of cell function caused by YTHDC1 overexpression. Knockdown of YTHDC1 or SQSTM1 enhanced autophagic flux, and knockdown of SQSTM1 led to a substantial reduction of the mTOR pathway activity. This study highlights the critical role of YTHDC1 and SQSTM1 in the invasive progression of RB. Their downregulation promoted autophagy in RB cells, providing preliminary evidence of their involvement in RB progression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.